{"doi":"10.1016/j.phrs.2022.106162","title":"Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer","abstract":null,"journal":"Pharmacological Research","year":2022,"id":233977,"datarank":2.910530967854794,"base_score":4.718498871295094,"endowment":4.718498871295094,"self_citation_contribution":0.7077748306942643,"citation_network_contribution":2.20275613716053,"self_endowment_contribution":0.7077748306942643,"citer_contribution":2.20275613716053,"corpus_percentile":null,"corpus_rank":null,"citation_count":111,"citer_count":104,"citers_with_citation_signal":82,"citers_with_endowment":82,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9506,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":253972,"name":"Tzu‐Ting Huang","orcid":"0000-0002-3675-2760","position":1,"is_corresponding":false},{"id":378984,"name":"Sachi Horibata","orcid":"0000-0002-2629-7821","position":2,"is_corresponding":false},{"id":242502,"name":"Jung‐Min Lee","orcid":"0000-0001-5456-7449","position":3,"is_corresponding":false},{"id":317421,"name":"Nitasha Gupta","orcid":"0000-0003-4337-2368","position":0,"is_corresponding":true}],"reference_count":89,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T00:21:31.237180Z","pmid":"35259479","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}